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Introduction
Klebsiella pneumoniae causes serious hospital-
acquired infections of the urinary tract, respiratory 
tract, surgical sites, and the bloodstream and can 
cause severe diseases, such as pneumonia, sepsis, and 
bacteremia (Maroncle et al. 2002; Paterson 2006).The 
resistance of K. pneumoniae has significantly increased 
with the rampant use of beta-lactam antibiotics, such 
as carbapenems. Carbapenems are often the last treat-
ment option for infections caused by these multidrug-
resistant bacteria. Therefore, the major concern is the 
development of resistance against carbapenems (Nord-
mann et al. 2011; Barwa and Shaaban 2017).
Klebsiella pneumoniae carbapenemase (KPC) is 
a  class-A β-lactamase, and the most active family of 
carbapenemases. The development of antibiotic resist-
ance by class-A Ambler enzymes, such as KPC, gen-
erally leads to increased cessation in the treatment of 
infections (Hashemi et al. 2014; Bachman et al. 2015; 
Barwa and Shaaban 2017). The strains possessing the 
blaKPC gene have spread worldwide; this has resulted 
in increased concern for healthcare services worldwide 
(Woodford et al. 2010). Detection of carbapenemases in 
Enterobacteriaceae is essential to control the develop-
ment of resistance in this family, particularly in K. pneu­
moniae isolates. The identification of K. pneumoniae 
isolates producing KPC has become a major concern 
for clinicians (Djahmi et al. 2014). 
In recent years, various phenotypic confirmatory 
tests to detect the presence of carbapenemase enzymes 
in Enterobacteriaceae have been evaluated by test-
ing the growth of such organisms in CHROMagar 
KPC medium, Chrom ID ESBL medium, Supercarba 
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A b s t r a c t
Klebsiella pneumoniae carbapenemase (KPC) have become a major therapeutic challenge because of its increasingly fast dissemination 
throughout the world. Accurate detection of KPC is essential for optimal treatment. The Clinical and Laboratory Standards Institutes 
(CLSI) for fast detection of KPC producers currently recommend Modified Hodge Test (MHT) and Carba NP test. MHT can directly 
detect carbapenemase production in Enterobacteriaceae isolates. The current study was conducted to evaluate the capacity of MHT with 
two carbapenem disks for accurate detection of KPC. MHT was performed according to guidelines of CLSI to identify isolates with carbap-
enem resistance. In doing so, two substrates of MHT were assigned into two groups for examination: meropenem and ertapenem groups. 
A total of 96 non-repetitive clinical isolates of Klebsiella pneumoniae were tested. The presence of the blaKPC gene in each MHT-positive 
isolate was examined by PCR. A total of 54 isolates exhibited reduced susceptibility or resistance to carbapenems. Sensitivity of MHT with 
two carbapenem disks was similar. Specificity of the MHT with meropenem disk was 64% and with ertapenem disk was 53%. Detection of 
KPC by MHT with meropenem disk was found to be more effective than with ertapenem disk. Based on our results, the presence of KPC 
does not in itself influence the categorization of resistance. Therefore, the use of MHT with ertapenem disk for the rapid detection of KPC 
among K. pneumoniae for infection control should not be recommended.
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medium and other tests, i.e., Neo sensitabs (Samra et al. 
2008; Nordmann et al. 2011; Aliskan et al. 2012; Hansen 
et al. 2012).
CLSI has recommended the use of MHT and Carba 
NP tests for carbapenemase detection in Enterobacte­
riaceae. Because of variations in sensitivity and specific-
ity for detection of KPC producers, the identification 
of such bacteria through these tests is difficult (Vasoo 
et al. 2013; Shinde et al. 2017). MHT has acceptable sen-
sitivity. It is easy to perform, inexpensive and feasible 
for practically all-clinical laboratories; however, it lacks 
specificity (Anderson et al. 2007; Pasteran et al. 2009; 
Pasteran et al. 2010). MHT was suggested for detection 
of carbapenemase-producers based on their in vivo pro-
duction of carbapenemases (Galani et al. 2008; Centers 
for Disease and Prevention 2009; Miriagou et al. 2010).
The purpose of this study was to evaluate the effec-
tiveness of MHT as a phenotypic confirmatory test with 
2 different substrates for KPC screening. Additionally, 
PCR was performed for the detection of blaKPC gene.
Experimental
Materials and Methods
Bacterial collection and Ribotyping analysis. 
K. pneu moniae isolates were collected from 96 consecu-
tive hospital inpatients and/or outpatients admitted to 
the AL Zahra hospital in Esfahan, Iran between Febru-
ary and June 2016. 
PCR amplification was used for PCR-ribotyping 
based on internal transcribed spacer (ITS). The proce-
dure implemented was as follows. Template DNA for the 
PCR was prepared from overnight culture of K. pneu­
moniae on nutrient agar (Scharlo, Spain). Five colonies 
from the overnight culture on TSA medium (Scharlo, 
Spain) were suspended in 100 µl distilled water. The 
boiling lysis method was used for DNA extraction. 
Cell debris was centrifuged at 13684 RCF for three 
minutes. Supernatants were used as the source of tem-
plate DNA for amplification. Strain identifications were 
performed by analysis of the ITS. PCR-ribotyping was 
performed using PCR Master Mix 2X (Thermo Scien- 
 tific, Germany) and specific primers (Liu et al. 2008).
Antimicrobial susceptibility testing. The disk dif-
fusion methods using meropenem, ertapenem disks 
(Rosco, Denmark) were conducted on the basis of CLSI 
recommendations. Escherichia coli ATCC 25922 and 
K. pneumoniae 700603 were used as reference strains 
for susceptibility testing (CLSI).
Phenotypic confirmation test. In our study all iso-
lates were subjected to MHT, according to the following 
procedure. Ertapenem disks (10 µg) (Rosco, Denmark), 
and meropenem disks (10 µg) (Rosco, Denmark) were 
used for MHT. The MHT indicator organism, E. coli 
ATCC 25922, was suspended in Mueller-Hinton broth 
(Scharlo, Spain) to obtain a suspension with turbidity of 
a 0.5 McFarland standard. The suspension was diluted 
1:10 and plated on Mueller-Hinton agar (Scharlo, 
Spain). The carbapenem disk was placed in the centre 
of plates, and the isolates were streaked from the mar-
gin to the central disk by sterile swab. Two isolates were 
tested per plate. The plates were then incubated at 35°C 
for 18–20 hours. The production of a clover leaf-like 
indentation of the E. coli ATCC 25922 growth indicated 
a positive result for MHT (CLSI).
Genotypic confirmation test. All isolates were sub-
jected to PCR to check for the presence of the blaKPC 
gene. K. pneumoniae ATCC BAA-1705 and K. pneu­
moniae ATCC BAA 1706 were used as quality control 
strains. A commercial DNA plasmid extraction kit 
was used (IBRC, Iran) to purify and characterize the 
plasmid DNA derived from the isolates. The primers 
used for amplification of blaKPC gene were designed 
in this study. The forward and reverse primers were 
Fig. 1. Result of antimicrobial susceptibility of positive MHT isolates by ertapenem disk. Antimicrobial susceptibility
of ertapenem disk and its patterns compared with existence of the blaKPC gene.
Results show that 25% isolates were MHT-negative and resistant to ertapenem disk.
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KPC-F: ATGTCACTGTATCGCCGTCT, and KPC-R: 
GCTGTGCTTGTCATCCTTGT (Fazabiotech, Iran), 
respectively. The primers were used at 1 µmol concen-
tration. The amplification product was expected to be 
819 bp in length. 
PCR reactions were performed using a thermocycler 
with the following conditions: initial denaturing at 95°C 
for 5 min, followed by 35 cycles of 60 sec of denatura-
tion at 95°C, annealing at 53°C for 30 sec, elongation at 
72°C for 90 sec, and a final extension at 72°C for 10 min.
Results
Bacterial isolation. A total of 96 K. pneumoniae 
were isolated from 96 different patients of whom 15.6% 
were outpatient and 84.4% were admitted to internal 
medicine wards. Clinical specimens included 30 urine, 
16 wound swabs, one peritoneal-fluid, 6 blood samples, 
34 respiratory secretions, and 9 other specimens.
Positive MHT patterns. 37 isolates were classi-
fied as carbapenem-resistant using MHT with the 
meropenem disk, and 47 with the ertapenem disk. 
A total of 54 isolates (some isolates showed positive 
result with the use of both disks) were classified as 
carbapenemase-producer. 
Antimicrobial susceptibility patterns. The anti-
microbial susceptibility test for two carbapenem anti-
biotics revealed that 49 isolates (51.04%) were resistant 
to ertapenem, and 60 isolates (62.5%) were resistant 
to meropenem. 
Antimicrobial susceptibility patterns based on 
MHT results. 25 percent of the isolates were resistant 
to ertapenem, whereas they showed negative results by 
MHT with ertapenem disk (Table I). Only 29 (30.2%) of 
the MHT-positive isolates with meropenem disk were 
resistant to meropenem (Table II).
Molecular analysis of blaKPC gene. Five of the 
54 isolates, which were carbapenem-resistant and pos-
sessed the blaKPC gene, were detected using PCR. Three 
of these 5 isolates exhibited MHT-positive phenotype 
with both disks, one with meropenem disk, and one 
with ertapenem.
Antimicrobial susceptibility of blaKPC gene. The 
disk diffusion method was interpreted for KPC-pro-
ducing K. pneumoniae isolates as follows: four isolates 
(4.17%) were resistant to carbapenem disks, two iso-
lates were sensitive to ertapenem disk, and one isolate 
(1.04%) was intermediate to meropenem disk.
MHT Negative 22.9% 3.1% 25.0%
 Positive 14.6% 8.3% 26.0%
Table I
Result of antimicrobial susceptibility patterna of MHTb
by ertapenem disk.
a The interpretation was performed based in CLSI guideline (M100-S25). 
Antimicrobial susceptibility tests were determined using disk diffusion 
methodology.
b MHT positive and negative results were interpreted using the CLSI 
guideline(M100-S25).
Sensitive ResistantIntermediate
MHT Negative 15.6% 13.5% 32.3%
 Positive  5.2%  3.1% 30.2%
Table II
Result of antimicrobial susceptibility patterna of MHTb
by meropenem disk.
a The interpretation was performed based in CLSI guideline (M100-S25). 
Antimicrobial susceptibility tests were determined using disk diffusion 
methodology.
b MHT positive and negative results were interpreted using the CLSI 
guideline (M100-S25).
Sensitive ResistantIntermediate
Fig. 2. Result of antimicrobial susceptibility of positive MHT isolates by meropenem disk.
Antimicrobial susceptibility of meropenem disk and its patterns compared with existence of the blaKPC gene.
Results show that 32.29% isolates were MHT-negative and resistant to meropenem disk.
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Discussion
The rapid detection of carbapenemase-producing 
strains in clinical samples is critically important to pro-
vide appropriate treatment. As a phenotypic test, MHT 
is widely used for first-line detection of carbapenem 
resistance in clinical laboratories (Carvalhaes et al. 
2010; Cury et al. 2012; Chande et al. 2013). In the cur-
rent study, we evaluated the efficiency of MHT test with 
two different carbapenem disks as substrate for identi-
fication of KPC enzyme and compared it using PCR. 
In this examination, 54 K. pneumoniae isolates were 
MHT-positive, while only five of them were carriers 
of blaKPC gene. Our finding seems to be consistent 
with those other studies that obtained false-positive 
results for MHT. Therefore, the use of MHT alone 
should not be recommended to confirm the presence 
of carbapenemase produced by Enterobacteriaceae 
(Bayramoglu et al. 2016)
Varying sensitivity and specificity of MHT were 
found in different studies (Doyle et al. 2012; Lari et al. 
2014; Shinde et al. 2017; Sun et al. 2017). One study 
revealed that MHT with ertapenem disk could be uti-
lized for the detection of carbapenemases in isolates 
that showed intermediate or sensitive zone diameter 
on disk diffusion (Amjad et al. 2011). Another study 
demonstrated that the MHT with ertapenem disk had 
positive predictive significance of KPC detection in 
Enterobacteriaceae (Cury et al. 2012).
Our results revealed that the sensitivity of MHT test 
with meropenem and ertapenem disks was equal (80%). 
Hence, using two carbapenem disks as a substrate for 
MHT led to excellent sensitivity for the detecting of 
KPC producers. The specificity of MHT with ertap-
enem and meropenem disks was found to be low: 53% 
and 64%, respectively. However, the specificity of ertap-
enem disk was much lower than the meropenem disk.
MHT cannot be considered as a good indicator for 
the detection of KPC producers because of its low spec-
ificity. The meropenem disk was more effective than 
ertapenem disk as a substrate for MHT. Nevertheless, 
MHT results alone are not sufficient to predict carbap-
enem resistance. One limitation of the study is that we 
did not detect other carbapenemase producers. MHT 
showed carbapenemase activity other than carbapen-
emase production. The resistance could be related to 
some other mechanisms. PCR yielded sufficient results 
for detection of KPC-producing isolates. We recom-
mended that improvement in MHT for the screening 
of KPC producers with high specificity is required for 
accurate detection.
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